Vaccines are among the hottest topics in biopharmaceuticals today. At the time of this article’s writing, 49.5% of the world’s population have already received at least one dose of a COVID-19 vaccine, and 26.65 million doses are being administered each day.1
The COVID-19 vaccines are a triumph, but they were almost somewhat expected—even though some commentators were predicting, as late as July 2020, that a COVID-19 vaccine could take years, or even decades, to develop.2 Looking back, we can appreciate that the vaccines were developed so quickly because of dramatic changes in vaccine production.